Gilbert Di Paolo is an accomplished scientist currently serving as the Seth and Amy Christensen Distinguished Scientist and Executive Director at Denali Therapeutics. Prior experience includes roles as Senior Director and Staff Scientist in Discovery Biology, and prior leadership positions as Director and Staff Scientist. Academic appointments include Associate Professor and Assistant Professor at Columbia University, as well as postdoctoral research at Yale University. Gilbert Di Paolo completed a PhD at the University of Lausanne and conducted graduate studies at the Glaxo Institute for Molecular Biology. Education was obtained from the University of Lausanne from 1988 to 1992.
April, 2022 - present
June, 2020
December, 2018